The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling-Reference-Cited by-同舟云学术

The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling

Published:2008-08-10 Issue:9 Volume:9 Page:1028-1036
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Ananieva Olga,Darragh Joanne,Johansen Claus,Carr Julia M,McIlrath Joanne,Park Jin Mo,Wingate Andrew,Monk Claire E,Toth Rachel,Santos Susana G,Iversen Lars,Arthur J Simon C

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.1644.pdf

Reference50 articles.

1. Kawai, T. & Akira, S. TLR signaling. Semin. Immunol. 19, 24–32 (2007).

2. Miggin, S.M. & O'Neill, L.A. New insights into the regulation of TLR signaling. J. Leukoc. Biol. 80, 220–226 (2006).

3. Lee, M.S. & Kim, Y.J. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu. Rev. Biochem. 76, 447–480 (2007).

4. Han, J., Lee, J.D., Bibbs, L. & Ulevitch, R.J.A. MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808–811 (1994).

5. Freshney, N.W. et al. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78, 1039–1049 (1994).

Cited by 281 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolonged extracellular low sodium concentrations and subsequent their rapid correction modulate nitric oxide production dependent on NFAT5 in microglia;Free Radical Biology and Medicine;2024-10

2. DNA methylation in peripheral blood is associated with renal aging and renal function decline: a national community study;Clinical Epigenetics;2024-06-15

3. NF-κB in biology and targeted therapy: new insights and translational implications;Signal Transduction and Targeted Therapy;2024-03-04

4. Polydopamine nanoparticles as a non-pharmaceutical tool in the treatment of fatty liver disease;Materials & Design;2024-03

5. Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology;Expert Reviews in Molecular Medicine;2024